POZEN Logo
Print Page   Close Window

Press Release

POZEN to Present at the Jefferies 2007 Healthcare Conference

CHAPEL HILL, N.C.--(BUSINESS WIRE)--June 14, 2007--POZEN Inc. (NASDAQ: POZN) announced today that William L. Hodges, the company's chief financial officer, will present at the Jefferies 2007 Healthcare Conference on Wednesday, June 27, 2007 at 8:40 a.m. (ET) at the Mandarin Oriental Hotel in New York City. Mr. Hodges' presentation will be webcast and archived on POZEN's home page at www.pozen.com.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for the proposed product candidate Trexima(TM) for the acute treatment of migraine, which is currently under review by the United States Food and Drug Administration, and with AstraZeneca for the proposed product candidate PN 400, for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

CONTACT: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
or
Fran Barsky, 919-913-1044
Director, Investor Relations

SOURCE: POZEN Inc.